Huub H D M van Vliet - JoVE Visualize

Showing results (1-10 of 19) with videos related to

Pageof 2

Sort By:

Acta Haematologica|June 10, 2009

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and managementJan Jacques Michiels, Huub H D M van Vliet

Platelets|May 25, 2004

Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia veraJan Jacques Michiels, Zwi N Berneman, Wilfried Schroyens, et al.

Acta Haematologica|June 10, 2009

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settingsJan Jacques Michiels, Huub H D M van Vliet, Zwi Berneman, et al.

Thrombosis and Haemostasis|September 4, 2008

PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2Huub H D M van Vliet, Mies C Kappers-Klunne, Frank W G Leebeek, et al.

Seminars in Thrombosis and Hemostasis|September 16, 2006

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia veraJan J Michiels, Zwi Berneman, Wilfried Schroyens, et al.

Blood Cells, Molecules & Diseases|March 3, 2006

Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadinJan Jacques Michiels, Zwi Berneman, Wilfried Schroyens, et al.

Acta Haematologica|June 10, 2009

Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1Jan Jacques Michiels, Zwi Berneman, Alain Gadisseur, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004

Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P)Jan Jacques Michiels, Zwi N Berneman, Marc van der Planken, et al.

Seminars in Thrombosis and Hemostasis|September 16, 2006

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implicationsJan J Michiels, Zwi Berneman, Alain Gadisseur, et al.

Seminars in Thrombosis and Hemostasis|May 7, 2002

Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implicationsJan J Michiels, Ann van de Velde, Huub H D M van Vliet, et al.

Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:

Pageof 2

Acta Haematologica|June 10, 2009

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and managementJan Jacques Michiels, Huub H D M van Vliet

Platelets|May 25, 2004

Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia veraJan Jacques Michiels, Zwi N Berneman, Wilfried Schroyens, et al.

Acta Haematologica|June 10, 2009

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settingsJan Jacques Michiels, Huub H D M van Vliet, Zwi Berneman, et al.

Thrombosis and Haemostasis|September 4, 2008

PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2Huub H D M van Vliet, Mies C Kappers-Klunne, Frank W G Leebeek, et al.

Seminars in Thrombosis and Hemostasis|September 16, 2006

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia veraJan J Michiels, Zwi Berneman, Wilfried Schroyens, et al.

Blood Cells, Molecules & Diseases|March 3, 2006

Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadinJan Jacques Michiels, Zwi Berneman, Wilfried Schroyens, et al.

Acta Haematologica|June 10, 2009

Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1Jan Jacques Michiels, Zwi Berneman, Alain Gadisseur, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004

Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P)Jan Jacques Michiels, Zwi N Berneman, Marc van der Planken, et al.

Seminars in Thrombosis and Hemostasis|September 16, 2006

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implicationsJan J Michiels, Zwi Berneman, Alain Gadisseur, et al.

Seminars in Thrombosis and Hemostasis|May 7, 2002

Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implicationsJan J Michiels, Ann van de Velde, Huub H D M van Vliet, et al.

Pageof 2